JP2023534189A5 - - Google Patents
Info
- Publication number
- JP2023534189A5 JP2023534189A5 JP2023501424A JP2023501424A JP2023534189A5 JP 2023534189 A5 JP2023534189 A5 JP 2023534189A5 JP 2023501424 A JP2023501424 A JP 2023501424A JP 2023501424 A JP2023501424 A JP 2023501424A JP 2023534189 A5 JP2023534189 A5 JP 2023534189A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- group
- aliphatic
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063050730P | 2020-07-10 | 2020-07-10 | |
| US63/050,730 | 2020-07-10 | ||
| PCT/US2021/041184 WO2022011318A1 (en) | 2020-07-10 | 2021-07-09 | Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534189A JP2023534189A (ja) | 2023-08-08 |
| JP2023534189A5 true JP2023534189A5 (https=) | 2024-07-17 |
Family
ID=79552105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501424A Pending JP2023534189A (ja) | 2020-07-10 | 2021-07-09 | Ｇａｂａａアルファ５アゴニストおよびｓｖ２ａ阻害剤の組合せ物ならびに認知障害の処置において使用する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230270753A1 (https=) |
| EP (1) | EP4178582A4 (https=) |
| JP (1) | JP2023534189A (https=) |
| CN (1) | CN116075302A (https=) |
| AU (1) | AU2021304356A1 (https=) |
| BR (1) | BR112023000423A2 (https=) |
| CA (1) | CA3189302A1 (https=) |
| IL (1) | IL299754A (https=) |
| MX (1) | MX2023000405A (https=) |
| WO (1) | WO2022011318A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7737721B2 (ja) * | 2019-12-19 | 2025-09-11 | エージンバイオ， インコーポレイテッド | 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法 |
| EP4504176A1 (en) * | 2022-04-01 | 2025-02-12 | Agenebio, Inc. | Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance |
| CN120584115A (zh) | 2022-08-19 | 2025-09-02 | 艾吉因生物股份有限公司 | 苯并氮杂䓬衍生物、组合物和用于治疗认知损害的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2865504T3 (es) * | 2008-10-16 | 2021-10-15 | Univ Johns Hopkins | Procedimientos y composiciones para la mejora de la función cognitiva |
| AU2011215870B2 (en) * | 2010-02-09 | 2016-01-28 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US20140206667A1 (en) * | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014153180A1 (en) * | 2013-03-14 | 2014-09-25 | Michela Gallagher | Methods and compositions for improving cognitive function |
| NZ760341A (en) * | 2013-12-20 | 2021-12-24 | Agenebio Inc | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| CN112601749B (zh) * | 2018-06-19 | 2024-03-26 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂环庚三烯衍生物，组合物和方法 |
-
2021
- 2021-07-09 CN CN202180062022.9A patent/CN116075302A/zh active Pending
- 2021-07-09 EP EP21836970.0A patent/EP4178582A4/en active Pending
- 2021-07-09 CA CA3189302A patent/CA3189302A1/en active Pending
- 2021-07-09 AU AU2021304356A patent/AU2021304356A1/en active Pending
- 2021-07-09 MX MX2023000405A patent/MX2023000405A/es unknown
- 2021-07-09 US US18/015,439 patent/US20230270753A1/en active Pending
- 2021-07-09 JP JP2023501424A patent/JP2023534189A/ja active Pending
- 2021-07-09 BR BR112023000423A patent/BR112023000423A2/pt unknown
- 2021-07-09 WO PCT/US2021/041184 patent/WO2022011318A1/en not_active Ceased
- 2021-07-09 IL IL299754A patent/IL299754A/en unknown
- 2021-07-09 US US17/372,405 patent/US20220062296A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023534189A5 (https=) | ||
| AU2018379992B2 (en) | Nonracemic mixtures and uses thereof | |
| JP2021528427A5 (https=) | ||
| CN105658624B (zh) | 甲酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 | |
| NZ788543A (en) | Dimethyltryptamine derivatives and their use in psychedelic-assisted psychotherapy | |
| EP1256576B1 (en) | Fused imidazolium derivatives | |
| HUT62875A (en) | Process for producing 2-aminomethyl chroman derivatives and pharmaceutical compositions comprising such compounds | |
| JP2018521034A5 (https=) | ||
| WO2000075113A1 (en) | Novel heterocyclic carboxamide derivatives | |
| JP2021515029A (ja) | Ｏ，ｏ’−二置換酒石酸エナンチオマーの添加によるラセミ体ニコチンのエナンチオマー分離 | |
| JP2017500334A5 (https=) | ||
| JP2025511277A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| MX2023014436A (es) | Compuestos de 3-pirrolilsulfonamida como antagonistas de gpr17. | |
| JP2023507569A5 (https=) | ||
| CA3255777A1 (en) | METHODS FOR PREVENTING OR SLOWING DOWN THE PROGRESSION OF COGNITIVE DECLINE OR DISORDER IN SUBJECTS WITH NORMAL COGNITIVE PERFORMANCE | |
| IL299754A (en) | Combinations of gaba alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairment | |
| JPH02193951A (ja) | フルオキセチン類似体 | |
| MX2025006404A (es) | Compuestos de pirrolil-sulfonamida fusionados | |
| IE65117B1 (en) | 1-(Pyridinylamino)-2-pyrrolidinones a process for their preparation and their use as medicaments | |
| JP2016539994A (ja) | α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法 | |
| BG100331A (bg) | Фармакологично активни енантиомери | |
| FR2877005A1 (fr) | Nouveaux derives d'arylpiperazine | |
| CN108727393B (zh) | 苯基二氮杂双环衍生物及其用途 | |
| JPH04234369A (ja) | ６−アルキルピリダジン誘導体、調製方法およびそれらを含有する医薬組成物 |